Clinical evaluation of Jinghua Weikang Capsule in the treatment of Helicobacter pylori infection in the elderly

Peking Univeisity First Hospital0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Aged >= 65 years, genders are unlimited;
•2. HP infection was diagnosed by urea 13C breath test, endoscopic rapid urease test or stool antigen test;
•3. Except for gastrointestinal tumor and other space occupying lesions through endoscope or abdominal CT, gastrointestinal ultrasound, gastrointestinal contrast radiography and other imaging test;
•4. There are more than two chronic diseases such as diabetes, dyslipidemia, cardiovascular and cerebrovascular diseases, hypertension, thyroid dysfunction, COPD, immune system diseases, or two or more drugs taken orally for a long time ( >= 3 months);
•5. No antibiotics within 1 month, no acid inhibitors or or bismuth agent within 2 weeks;
•6. The subjects (or legal representatives) voluntarily consented and signed informed consent and were able to follow the research program during the study.

•1. Having a history of gastric surgery;
•2. Having active gastrointestinal bleeding and peptic ulcer;
•3. With serious diseases affecting the evaluation of the study, such as serious liver disease, heart disease, kidney disease, malignant tumor and alcoholism;
•4. Allergic to the drugs applied in the study;
•5. With low lung function;
•6. Having participated in other drug clinical studies within 3 months before participating in this project;
•7. Patients could not express their subjective feelings correctly and could not cooperate with each other.

发起方

Peking Univeisity First Hospital